X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (10) 10
children (9) 9
pediatrics (8) 8
hematology (7) 7
humans (7) 7
oncology (7) 7
adolescent (6) 6
cancer (6) 6
child (6) 6
child, preschool (6) 6
female (6) 6
infant (6) 6
male (6) 6
medical and health sciences (6) 6
medicin och hälsovetenskap (6) 6
pediatrik (6) 6
therapy (6) 6
acute lymphatic leukemia (5) 5
clinical medicine (5) 5
klinisk medicin (5) 5
leukemia (5) 5
precursor cell lymphoblastic leukemia-lymphoma - drug therapy (5) 5
risk (5) 5
toxicity (5) 5
6-mercaptopurine (4) 4
acute lymphocytic leukemia (4) 4
asparaginase (4) 4
chemotherapy (4) 4
methotrexate (4) 4
risk factors (4) 4
cancer and oncology (3) 3
cancer och onkologi (3) 3
care and treatment (3) 3
deoxyribonucleic acid--dna (3) 3
follow-up studies (3) 3
hematologi (3) 3
lymphatic leukemia (3) 3
mercaptopurine (3) 3
metabolites (3) 3
nucleotides (3) 3
patients (3) 3
prospective studies (3) 3
6-thioguanine (2) 2
acute lymphoblastic leukemia (2) 2
acute lymphoblastic-leukemia (2) 2
adult (2) 2
antineoplastic combined chemotherapy protocols - administration & dosage (2) 2
antineoplastic combined chemotherapy protocols - adverse effects (2) 2
antineoplastic combined chemotherapy protocols - therapeutic use (2) 2
asparaginase - administration & dosage (2) 2
asparaginase - adverse effects (2) 2
clinical trials (2) 2
cytotoxicity (2) 2
enzymes (2) 2
erwinia asparaginase (2) 2
expression (2) 2
genetic aspects (2) 2
genetic research (2) 2
genomes (2) 2
genotypes (2) 2
health aspects (2) 2
hematology, oncology and palliative medicine (2) 2
hypersensitivity (2) 2
lymphocytes b (2) 2
maintenance (2) 2
maintenance therapy (2) 2
medicine & public health (2) 2
metaanalysis (2) 2
methotrexate - administration & dosage (2) 2
mutation (2) 2
precursor cell lymphoblastic leukemia-lymphoma - blood (2) 2
precursor cell lymphoblastic leukemia-lymphoma - genetics (2) 2
prognosis (2) 2
red blood cells (2) 2
thioguanine (2) 2
treatment outcome (2) 2
5'-nucleotidase (1) 1
6‐mercaptopurine (1) 1
acute leukaemia (1) 1
acute lymphoblastic leukaemia (1) 1
acute lymphoblastic leukaemia; clinical trial; chemotherapy; children; toxicity; registration (1) 1
acute lymphoblastic leukemia maintenance therapy (1) 1
acute lymphoblastic leukemia; adults; children; treatment; toxicity (1) 1
adjustment (1) 1
adolescents (1) 1
adrenal cortex hormones - adverse effects (1) 1
adults (1) 1
age (1) 1
all2008 protocol (1) 1
allergy (1) 1
allergy in children (1) 1
aminopterin (1) 1
aml (1) 1
analysis (1) 1
anaphylaxis - chemically induced (1) 1
antibodies (1) 1
anticoagulants - adverse effects (1) 1
anticoagulants - therapeutic use (1) 1
antimetabolites (1) 1
antimitotic agents (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet Oncology, The, ISSN 1470-2045, 2017, Volume 18, Issue 4, pp. 515 - 524
Journal Article
Cancer Chemotherapy and Pharmacology, ISSN 0344-5704, 1/2019, Volume 83, Issue 1, pp. 53 - 60
Journal Article
British Journal of Haematology, ISSN 0007-1048, 02/2019, Volume 184, Issue 3, pp. 405 - 417
Journal Article
Journal Article
Leukemia, ISSN 0887-6924, 12/2018, Volume 32, Issue 12, pp. 2527 - 2535
Journal Article
Pediatric Blood & Cancer, ISSN 1545-5009, 10/2017, Volume 64, Issue 10, pp. e26518 - n/a
Background The improved survival rates for childhood acute lymphoblastic leukemia (ALL) may be jeopardized by the development of a second cancer, which has... 
methotrexate | childhood acute lymphoblastic leukemia | 6‐mercaptopurine | second cancer | 6-mercaptopurine | EPIPODOPHYLLOTOXINS | NOPHO | MAINTENANCE THERAPY | CHILDHOOD-CANCER | ONCOLOGY | PEDIATRICS | CUMULATIVE INCIDENCE | METHOTREXATE/6-MERCAPTOPURINE | HEMATOLOGY | SURVIVORS | MALIGNANT NEOPLASMS | Translocation, Genetic | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Precursor Cell Lymphoblastic Leukemia-Lymphoma - epidemiology | Follow-Up Studies | Humans | Methyltransferases - metabolism | Risk Factors | Methyltransferases - genetics | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Chromosomes, Human, Pair 21 - genetics | Neoplasms, Second Primary - epidemiology | Precursor Cell Lymphoblastic Leukemia-Lymphoma - genetics | Precursor Cell Lymphoblastic Leukemia-Lymphoma - drug therapy | Neoplasms, Second Primary - blood | Ploidies | Adolescent | Female | Retrospective Studies | Neoplasms, Second Primary - genetics | Neoplasms, Second Primary - drug therapy | Child | Chromosomes, Human, Pair 12 - genetics | Precursor Cell Lymphoblastic Leukemia-Lymphoma - blood | Acute lymphocytic leukemia | Methotrexate | Health aspects | Blood cell count | Risk factors | Mercaptopurine | Therapy | Acute lymphatic leukemia | Risk groups | Adjustment | Leukemia | Blood cells | Methyltransferase | Health risks | Runx1 protein | Risk | Maintenance | Lymphatic leukemia | Patients | Lymphocytes B | Health hazards | Remission | Thiopurine S-methyltransferase | Children | Cancer | Pediatrics | Medical and Health Sciences | Hematology | Medicin och hälsovetenskap | Pediatrik | Klinisk medicin | Clinical Medicine | Hematologi | Cancer and Oncology | Cancer och onkologi
Journal Article
British journal of haematology, ISSN 1365-2141, 2019, Volume 184, Issue 3, p. 405
Asparaginase is essential in childhood acute lymphoblastic leukaemia (ALL) treatment, however hypersensitivity reactions to pegylated asparaginase... 
Pediatrics | Pediatrik
Journal Article
Blood, ISSN 0006-4971, 11/2019, Volume 134, Issue Supplement_1, pp. 2755 - 2755
Background: PCR of rearranged antigen receptor genes is the method of choice for MRD quantification in ALL. Although FCM-MRD is faster and biologically more... 
Journal Article
British Journal of Haematology, ISSN 0007-1048, 02/2015, Volume 168, Issue 4, pp. 547 - 552
Journal Article
European Journal of Cancer, ISSN 0959-8049, 2013, Volume 50, Issue 2, pp. 251 - 259
Journal Article
European Journal of Haematology, ISSN 0902-4441, 02/2016, Volume 96, Issue 2, pp. 160 - 169
Objectives Cure rates improve when adolescents and young adults with acute lymphoblastic leukemia (ALL) are treated according to pediatric protocols. Assumed... 
toxicity | treatment | acute lymphoblastic leukemia | children | adults | Adults | Treatment | Children | Acute lymphoblastic leukemia | Toxicity | YOUNG-ADULTS | TRIALS | ASPARAGINASE | COMPLICATION | ALL2008 PROTOCOL | CANCER GROUP | OSTEONECROSIS | CHEMOTHERAPY | THERAPY | ADOLESCENTS | HEMATOLOGY | Thrombosis - chemically induced | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Prognosis | Humans | Middle Aged | Child, Preschool | Infant | Male | Methotrexate - toxicity | Osteonecrosis - pathology | Osteonecrosis - genetics | Precursor Cell Lymphoblastic Leukemia-Lymphoma - drug therapy | Vincristine - administration & dosage | Adult | Female | Precursor Cell Lymphoblastic Leukemia-Lymphoma - pathology | Child | Philadelphia Chromosome | Osteonecrosis - diagnosis | Prednisone - administration & dosage | Vincristine - toxicity | Treatment Outcome | Precursor Cell Lymphoblastic Leukemia-Lymphoma - diagnosis | Remission Induction | Antineoplastic Combined Chemotherapy Protocols - toxicity | Precursor Cell Lymphoblastic Leukemia-Lymphoma - genetics | Thrombosis - pathology | Adolescent | Methotrexate - administration & dosage | Thrombosis - genetics | Osteonecrosis - chemically induced | Prednisone - toxicity | Thrombosis - diagnosis | Genetic research | Genetic aspects | Acute lymphocytic leukemia | Cancer | Target marketing | Index Medicus | Clinical Medicine | Medical and Health Sciences | Hematology | Hematologi | Medicin och hälsovetenskap | acute lymphoblastic leukemia; adults; children; treatment; toxicity | Klinisk medicin | Cancer and Oncology | Cancer och onkologi
Journal Article